The European Medicines Agency (EMA) offered a positive opinion last week on a new artificial intelligence (AI)–based tool that supports pathologists in diagnosing and assessing the severity of ...

An eye drop formulation intended to slow progression of myopia in children has been recommended for a marketing authorization by the European Medicines Agency (EMA). Ryjunea, developed by Santen ...